Prolonged colonisation with escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014

Eurosurveillance

Volumn 21, Issue 42, 2016, Pages

  Overdevest, Ilse ^a,b   Haverkate, M ^d   Veenemans, J ^b,c   Hendriks, Y ^b,e   Verhulst, C ^b   Mulders, A ^e   Couprie, W ^e   Bootsma, M ^d,f   Johnson, J ^g   Kluytmans, J ^b,c,d  

^a Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e Thebe long term care facilities   (Netherlands)

^f UTRECHT UNIVERSITY   (Netherlands)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; BETA LACTAMASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ESCHERICHIA COLI; FEMALE; HEALTH CARE SURVEY; HUMAN; HYGIENE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL COLONIZATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; SEDIMENTATION RATE; SURVIVAL ANALYSIS; VERY ELDERLY; BIOSYNTHESIS; CLASSIFICATION; ESCHERICHIA COLI INFECTIONS; FECES; GENETICS; GENOTYPE; HETEROZYGOTE; ISOLATION AND PURIFICATION; LONG TERM CARE; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; NETHERLANDS; NURSING HOME; PROSPECTIVE STUDY; RECTUM;

BETA-LACTAMASES; CARRIER STATE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; GENOTYPE; HUMANS; LENGTH OF STAY; LONG-TERM CARE; MOLECULAR EPIDEMIOLOGY; NETHERLANDS; NURSING HOMES; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; RECTUM;

EID: 85013829484     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.42.30376     Document Type: Article

References (39)

1. Bush K. Extended-spectrum beta-lactamases in North America, 1987-2006.Clin Microbiol Infect. 2008;14(Suppl 1):134-43. DOI: 10.1111/j.1469-0691.2007.01848.x PMID:: 18154537
2. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008;14(Suppl 1):144-53. DOI: 10.1111/j.1469-0691.2007.01850.x PMID:: 18154538
3. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs.Clin Infect Dis. 2006;42(Suppl 2):S82-9. DOI: 10.1086/499406 PMID:: 16355321
4. Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M, Trecarichi EM, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-β- lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54(10):4085-91. DOI: 10.1128/AAC.00143-10 PMID:: 20660675
5. Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.J Antimicrob Chemother. 2008;62(5):1142-9. DOI: 10.1093/jac/dkn293 PMID:: 18641033
6. Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Cantón R, et al. High rate of intestinal colonization with extendedspectrum- β-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol. 2008;46(8):2796-9. DOI: 10.1128/JCM.01008-08 PMID:: 18562591
7. Alsterlund R, Carlsson B, Gezelius L, Haeggman S, Olsson- Liljequist B. Multiresistant CTX-M-15 ESBL-producing Escherichia coli in southern Sweden: Description of an outbreak.Scand J Infect Dis. 2009;41(6-7):410-5. DOI: 10.1080/00365540902896079 PMID:: 19396721
8. Lautenbach E, Han J, Santana E, Tolomeo P, Bilker WB, Maslow J. Colonization with extended-spectrum β-lactamaseproducing Escherichia coli and Klebsiella species in longterm care facility residents.Infect Control Hosp Epidemiol. 2012;33(3):302-4. DOI: 10.1086/664055 PMID:: 22314070
9. Jans B, Schoevaerdts D, Huang T-D, Berhin C, Latour K, Bogaerts P, et al. Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One. 2013;8(5):e64908. DOI: 10.1371/journal.pone.0064908 PMID:: 23738011
10. Hilty M, Betsch BY, Bögli-Stuber K, Heiniger N, Stadler M, Küffer M, et al. Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012;55(7):967-75. DOI: 10.1093/cid/cis581 PMID:: 22718774
11. Willemsen I, Nelson-Melching J, Hendriks Y, et al. Measuring the quality of infection control in Dutch nursing homes using a standardized method; the Infection prevention RIsk Scan (IRIS). Antimicrob Resist Infect Control. 2014;18(3):26.
12. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis. 2011;17(7):1216-22. DOI: 10.3201/eid1707.110209 PMID:: 21762575
13. Werkgroep infectiepreventie. Richtlijn: Bijzonder resistente micro-organismen (BRMO). [Guideline for highly resistant micro-organisms]. 2013. Dutch. Available from: http://www.rivm.nl/dsresource?objectid=rivmp:46410&type=org&disposit ion=inline&ns_nc=1
14. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis. 2008;14(2):195-200. DOI: 10.3201/eid1402.070350 PMID:: 18258110
15. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b- ST131: a pandemic, multiresistant, community-associated strain.J Antimicrob Chemother. 2011;66(1):1-14. DOI: 10.1093/jac/dkq415 PMID:: 21081548
16. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.Clin Infect Dis. 2010;51(3):286-94. DOI: 10.1086/653932 PMID:: 20572763
17. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother. 2008;61(2):273-81. DOI: 10.1093/jac/dkm464 PMID:: 18077311
18. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.Infect Control Hosp Epidemiol. 2013;34(4):361-9. DOI: 10.1086/669865 PMID:: 23466908
19. van der Donk CFM, Schols JMGA, Driessen CJ, Hagenouw RGP, Meulendijks A, Stobberingh EE. Prevalence and spread of multidrug resistant Escherichia coli isolates among nursing home residents in the southern part of The Netherlands.J Am Med Dir Assoc. 2013;14(3):199-203. DOI: 10.1016/j.jamda.2012.09.026 PMID:: 23141211
20. EUCAST.org. [Internet]. European committee of antimicrobial susceptibility testing. [Accessed 1 Jan 2014]. Available from: http://www.eucast.org/clinical_breakpoints/
21. Bernards AT, Bonten MJM, Cohen Stuart J, et al. NVMM Guideline - Laboratory detection of highly resistant microorganisms (HRMO). 2012. Available from: http://www.nvmm.nl/system/files/2012.11.15%20richtlijn%20BRMO%20 (version%202.0)%20-%20RICHTLIJN.pdf
22. Doumith M, Day MJ, Hope R, Wain J, Woodford N. Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups.J Clin Microbiol. 2012;50(9):3108-10. DOI: 10.1128/JCM.01468-12 PMID:: 22785193
23. Dhanji H, Doumith M, Clermont O, Denamur E, Hope R, Livermore DM, et al. Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum β-lactamases. Int J Antimicrob Agents. 2010;36(4):355-8. DOI: 10.1016/j.ijantimicag.2010.06.007 PMID:: 20691573
24. Cohen Stuart J, Dierikx C, Al Naiemi N, Karczmarek A, Van Hoek AH, Vos P, et al. Rapid detection of TEM, SHV and CTX-M extended-spectrum β-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother. 2010;65(7):1377-81. DOI: 10.1093/jac/dkq146 PMID:: 20462947
25. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM).J Antimicrob Chemother. 2012;67(8):1865-9. DOI: 10.1093/jac/dks156 PMID:: 22604450
26. Savelkoul PHM, Aarts HJM, de Haas J, Dijkshoorn L, Duim B, Otsen M, et al. Amplified-fragment length polymorphism analysis: the state of an art. J Clin Microbiol. 1999;37(10):3083-91.PMID: 10488158
27. Diekman O, Heesterbeek H, Britton T, editors. Mathematical tools for understanding infectious disease dynamic. 1st Ed. Princeton (ND): Princeton university press; 2012.
28. Tiengrim S, Thamlikitkul V. Inhibitory activity of fermented milk with Lactobacillus casei strain Shirota against common multidrug-resistant bacteria causing hospital-acquired infections. J Med Assoc Thai. 2012;95(Suppl 2):S1-5. PMID: 22574523
29. Singh R, van Nood E, Nieuwdorp M, van Dam B, ten Berge IJM, Geerlings SE, et al. Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease. Clin Microbiol Infect. 2014;20(11):O977-8. DOI: 10.1111/1469-0691.12683 PMID:: 24845223
30. Oostdijk EAN, de Smet AMGA, Kesecioglu J, Bonten MJM, Dutch SOD-SDD Trialists Group. Decontamination of cephalosporinresistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units.J Antimicrob Chemother. 2012;67(9):2250-3. DOI: 10.1093/jac/dks187 PMID:: 22643189
31. Buehlmann M, Bruderer T, Frei R, Widmer AF. Effectiveness of a new decolonisation regimen for eradication of extendedspectrum β-lactamase-producing Enterobacteriaceae.J Hosp Infect. 2011;77(2):113-7. DOI: 10.1016/j.jhin.2010.09.022 PMID:: 21194789
32. Huttner B, Haustein T, Uçkay I, Renzi G, Stewardson A, Schaerrer D, et al. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, doubleblind, placebo-controlled trial. J Antimicrob Chemother. 2013;68(10):2375-82.PMID: 23719234
33. Alsterlund R, Axelsson C, Olsson-Liljequist B. Long-term carriage of extended-spectrum beta-lactamase-producing Escherichia coli.Scand J Infect Dis. 2012;44(1):51-4. DOI: 10.3109/00365548.2011.592987 PMID:: 21736509
34. Haverkate MR, Derde LPG, Brun-Buisson C, Bonten MJM, Bootsma MCJ. Duration of colonization with antimicrobialresistant bacteria after ICU discharge.Intensive Care Med. 2014;40(4):564-71. DOI: 10.1007/s00134-014-3225-8 PMID:: 24522879
35. Apisarnthanarak A, Bailey TC, Fraser VJ. Duration of stool colonization in patients infected with extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.Clin Infect Dis. 2008;46(8):1322-3. DOI: 10.1086/533475 PMID:: 18444877
36. Zahar JR, Lanternier F, Mechai F, Filley F, Taieb F, Mainot EL, et al. Duration of colonisation by Enterobacteriaceae producing extended-spectrum β-lactamase and risk factors for persistent faecal carriage. J Hosp Infect. 2010;75(1):76-8. DOI: 10.1016/j.jhin.2009.11.010 PMID:: 20227136
37. Barreto Miranda I, Ignatius R, Pfuller R, et al. High carriage rate of ESBL-producing Enterobacteriaceae at presentation and follow-up among travellers with gastrointestinal complaints returning from India and Southeast Asia. J Travel Med. 2016;23(2):Epub.
38. Titelman E, Hasan CM, Iversen A, Nauclér P, Kais M, Kalin M, et al. Faecal carriage of extended-spectrum β-lactamaseproducing Enterobacteriaceae is common 12 months after infection and is related to strain factors. Clin Microbiol Infect. 2014;20(8):O508-15. DOI: 10.1111/1469-0691.12559 PMID:: 24450760
39. Adler A, Gniadkowski M, Baraniak A, Izdebski R, Fiett J, Hryniewicz W, et al., MOSAR WP5 and WP2 study groups. Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre.Clin Microbiol Infect. 2012;18(12):E497-505. DOI: 10.1111/j.1469-0691.2012.03999.x PMID:: 22963432